Screening for diabetes in patients on long-term glucocorticoid therapy
Diabetes Screening in Patients on Long-Term Glucocorticoid Therapy
Centre Hospitalier Universitaire Dijon · NCT04258293
This study is testing how often diabetes develops in people who have been taking glucocorticoids for a long time to see if they need better monitoring and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire Dijon (other) |
| Locations | 1 site (Dijon) |
| Trial ID | NCT04258293 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who are undergoing long-term glucocorticoid therapy, which is commonly prescribed for various inflammatory and autoimmune conditions. The study aims to assess the incidence of corticosteroid-induced diabetes in non-diabetic patients receiving glucocorticoids for more than three months. Blood samples will be collected to monitor glucose levels and evaluate the potential development of diabetes due to glucocorticoid treatment. The findings could help in identifying at-risk patients and improving management strategies.
Who should consider this trial
Good fit: Ideal candidates are non-diabetic patients who are prescribed glucocorticoids for more than three months.
Not a fit: Patients who are already diabetic or have recently received corticosteroid therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better screening and management of diabetes in patients receiving glucocorticoid therapy.
How similar studies have performed: Previous studies have indicated a significant incidence of corticosteroid-induced diabetes, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Person who has orally provided voluntary informed consent. * Patient with an indication for prolonged corticosteroid therapy (more than three months) * Non-diabetic patient Exclusion Criteria: * Person not affiliated to or not benefiting from national health insurance system * Person subject to legal protection (guardianship, curatorship) * Pregnant or breastfeeding woman * Adult unable to provide consent * Minor * Evidence of fasting venous blood glucose greater than 1.26 g/L, or Glycated haemoglobin greater than 6.5% at the time of initial blood sampling before glucocorticoid treatment. * Patient who had received corticosteroid therapy within 3 months prior to the study * Patient with hemoglobin less than 10 g/dL
Where this trial is running
Dijon
- CHU Dijon Bourgogne — Dijon, France (RECRUITING)
Study contacts
- Study coordinator: Benjamin BOUILLET
- Email: benjamin.bouillet@chu-dijon.fr
- Phone: 03.80.29.34.53
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Glucocorticosteroid, Diabetes